{"data":{"id":"us-il/30-ilcs-785-20","jurisdiction":"us-il","citation":"30 ILCS 785/20","heading":"Manner of conducting trial.","body":"In a clinical trial in which women or members of minority groups will be included as subjects as required under Section 10, a grantee must ensure that the trial is designed and carried out in a manner sufficient to provide for a valid analysis of whether the variables being studied in the trial affect women or members of minority groups, as the case may be, differently than other subjects in the trial.","path":["CHAPTER 30 FINANCE","Inclusion of Women and Minorities in Clinical Research Act."],"source_url":"https://www.ilga.gov/legislation/ILCS/details?ActID=2452\u0026ChapterID=7\u0026ChapAct=FullText\u0026Print=True","current_through":"at least Public Act 104-790","vintage":"","retrieved_at":"2026-09-15T04:46:19Z","sha256":"22f8d92baa940af24b9fdf972fe73d4b4ded0c1cef598276e1ba6be0cfcab0ad","source_id":"us-il","stale":false,"prev":"us-il/30-ilcs-785-15","next":"us-il/30-ilcs-785-25"},"notice":"GroundRules: Original legal text. Not legal advice."}
